Serum HBsAg and HBcrAg is associated with inflammation in HBeAg-positive chronic hepatitis B patients. 2023

Jing Zhao, and Dandan Bian, and Hao Liao, and Yang Wang, and Yan Ren, and Yingying Jiang, and Shuang Liu, and Xinyue Chen, and Zhongjie Hu, and Zhongping Duan, and Fengmin Lu, and Sujun Zheng
Liver Disease Center, Beijing YouAn Hospital, Capital Medical University, Beijing, China.

Liver inflammation is the main risk factor for developing liver fibrosis, cirrhosis, and even hepatocellular carcinoma in chronic hepatitis B (CHB) patients. To replace biopsy, additional non-invasive biomarkers to diagnose and grade liver necroinflammation are urgently required in clinical practice. Ninety-four CHB patients, including 74 HBeAg-positive and 20 HBeAg-negative patients, were enrolled and started entecavir or adefovir therapy. Serum HBV RNA, HBV DNA, HBsAg, hepatitis B core-related antigen (HBcrAg), ALT and AST levels, as well as intrahepatic HBV DNA and cccDNA were measured at baseline and during treatment. Liver inflammation was assessed at baseline and month 60 by liver biopsy. Inflammation regression was defined as a ≥1-grade decrease according to the Scheuer scoring system. In HBeAg-positive CHB patients, at baseline, serum HBsAg and HBcrAg levels negatively correlated with inflammation grade, while ALT and AST levels positively correlated with inflammation grade. AST plus HBsAg exhibited excellent diagnostic ability for significant inflammation with an AUROC of 0.896. After 60 months of antiviral treatment, almost all the patients' liver inflammation ameliorated to G1, and no patients had inflammation progression. Besides ALT and AST, serum HBsAg and HBcrAg correlated with inflammation grade in HBeAg-positive CHB patients before NAs treatment. Moreover, the combination of HBsAg and AST exhibited excellent diagnostic ability for significant inflammation.

UI MeSH Term Description Entries
D007249 Inflammation A pathological process characterized by injury or destruction of tissues caused by a variety of cytologic and chemical reactions. It is usually manifested by typical signs of pain, heat, redness, swelling, and loss of function. Innate Inflammatory Response,Inflammations,Inflammatory Response, Innate,Innate Inflammatory Responses
D008103 Liver Cirrhosis Liver disease in which the normal microcirculation, the gross vascular anatomy, and the hepatic architecture have been variably destroyed and altered with fibrous septa surrounding regenerated or regenerating parenchymal nodules. Cirrhosis, Liver,Fibrosis, Liver,Hepatic Cirrhosis,Liver Fibrosis,Cirrhosis, Hepatic
D008113 Liver Neoplasms Tumors or cancer of the LIVER. Cancer of Liver,Hepatic Cancer,Liver Cancer,Cancer of the Liver,Cancer, Hepatocellular,Hepatic Neoplasms,Hepatocellular Cancer,Neoplasms, Hepatic,Neoplasms, Liver,Cancer, Hepatic,Cancer, Liver,Cancers, Hepatic,Cancers, Hepatocellular,Cancers, Liver,Hepatic Cancers,Hepatic Neoplasm,Hepatocellular Cancers,Liver Cancers,Liver Neoplasm,Neoplasm, Hepatic,Neoplasm, Liver
D004270 DNA, Circular Any of the covalently closed DNA molecules found in bacteria, many viruses, mitochondria, plastids, and plasmids. Small, polydisperse circular DNA's have also been observed in a number of eukaryotic organisms and are suggested to have homology with chromosomal DNA and the capacity to be inserted into, and excised from, chromosomal DNA. It is a fragment of DNA formed by a process of looping out and deletion, containing a constant region of the mu heavy chain and the 3'-part of the mu switch region. Circular DNA is a normal product of rearrangement among gene segments encoding the variable regions of immunoglobulin light and heavy chains, as well as the T-cell receptor. (Riger et al., Glossary of Genetics, 5th ed & Segen, Dictionary of Modern Medicine, 1992) Circular DNA,Circular DNAs,DNAs, Circular
D004279 DNA, Viral Deoxyribonucleic acid that makes up the genetic material of viruses. Viral DNA
D006512 Hepatitis B Core Antigens The hepatitis B antigen within the core of the Dane particle, the infectious hepatitis virion. HBcAg,Hepatitis B Core Antigen
D006513 Hepatitis B e Antigens A closely related group of antigens found in the plasma only during the infective phase of hepatitis B or in virulent chronic hepatitis B, probably indicating active virus replication; there are three subtypes which may exist in a complex with immunoglobulins G. HBeAg,Hepatitis B e Antigen,Hepatitis Be Antigen,e Antigen,e Antigens,HBe Ag-1,HBe Ag-2,Hepatitis Be Antigens,Antigen, Hepatitis Be,Antigen, e,Antigens, Hepatitis Be,Antigens, e,Be Antigen, Hepatitis,Be Antigens, Hepatitis
D006514 Hepatitis B Surface Antigens Those hepatitis B antigens found on the surface of the Dane particle and on the 20 nm spherical and tubular particles. Several subspecificities of the surface antigen are known. These were formerly called the Australia antigen. Australia Antigen,HBsAg,Hepatitis B Surface Antigen,Antigen, Australia
D006515 Hepatitis B virus The type species of the genus ORTHOHEPADNAVIRUS which causes human HEPATITIS B and is also apparently a causal agent in human HEPATOCELLULAR CARCINOMA. The Dane particle is an intact hepatitis virion, named after its discoverer. Non-infectious spherical and tubular particles are also seen in the serum. Dane Particle,Hepatitis Virus, Homologous Serum,B virus, Hepatitis,Hepatitis B viruses,Particle, Dane,viruses, Hepatitis B
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

Jing Zhao, and Dandan Bian, and Hao Liao, and Yang Wang, and Yan Ren, and Yingying Jiang, and Shuang Liu, and Xinyue Chen, and Zhongjie Hu, and Zhongping Duan, and Fengmin Lu, and Sujun Zheng
March 2015, Jundishapur journal of microbiology,
Jing Zhao, and Dandan Bian, and Hao Liao, and Yang Wang, and Yan Ren, and Yingying Jiang, and Shuang Liu, and Xinyue Chen, and Zhongjie Hu, and Zhongping Duan, and Fengmin Lu, and Sujun Zheng
August 2006, Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences,
Jing Zhao, and Dandan Bian, and Hao Liao, and Yang Wang, and Yan Ren, and Yingying Jiang, and Shuang Liu, and Xinyue Chen, and Zhongjie Hu, and Zhongping Duan, and Fengmin Lu, and Sujun Zheng
March 2018, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases,
Jing Zhao, and Dandan Bian, and Hao Liao, and Yang Wang, and Yan Ren, and Yingying Jiang, and Shuang Liu, and Xinyue Chen, and Zhongjie Hu, and Zhongping Duan, and Fengmin Lu, and Sujun Zheng
November 2016, Journal of viral hepatitis,
Jing Zhao, and Dandan Bian, and Hao Liao, and Yang Wang, and Yan Ren, and Yingying Jiang, and Shuang Liu, and Xinyue Chen, and Zhongjie Hu, and Zhongping Duan, and Fengmin Lu, and Sujun Zheng
February 2021, Journal of hepatology,
Jing Zhao, and Dandan Bian, and Hao Liao, and Yang Wang, and Yan Ren, and Yingying Jiang, and Shuang Liu, and Xinyue Chen, and Zhongjie Hu, and Zhongping Duan, and Fengmin Lu, and Sujun Zheng
January 2015, Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology,
Jing Zhao, and Dandan Bian, and Hao Liao, and Yang Wang, and Yan Ren, and Yingying Jiang, and Shuang Liu, and Xinyue Chen, and Zhongjie Hu, and Zhongping Duan, and Fengmin Lu, and Sujun Zheng
April 2014, World journal of gastroenterology,
Jing Zhao, and Dandan Bian, and Hao Liao, and Yang Wang, and Yan Ren, and Yingying Jiang, and Shuang Liu, and Xinyue Chen, and Zhongjie Hu, and Zhongping Duan, and Fengmin Lu, and Sujun Zheng
January 2017, Journal of medical virology,
Jing Zhao, and Dandan Bian, and Hao Liao, and Yang Wang, and Yan Ren, and Yingying Jiang, and Shuang Liu, and Xinyue Chen, and Zhongjie Hu, and Zhongping Duan, and Fengmin Lu, and Sujun Zheng
January 2019, Journal of clinical microbiology,
Jing Zhao, and Dandan Bian, and Hao Liao, and Yang Wang, and Yan Ren, and Yingying Jiang, and Shuang Liu, and Xinyue Chen, and Zhongjie Hu, and Zhongping Duan, and Fengmin Lu, and Sujun Zheng
August 2018, Journal of viral hepatitis,
Copied contents to your clipboard!